Please login to the form below

Not currently logged in
Email:
Password:

side effects

This page shows the latest side effects news and features for those working in and with pharma, biotech and healthcare.

Roche’s MabThera beats incumbent drug in pemphigus vulgaris phase 3

Roche’s MabThera beats incumbent drug in pemphigus vulgaris phase 3

Now, Roche has presented data comparing MabThera to mycophenolate mofetil, one of the immunosuppressants physicians prescribe to spare patients from the side effects of long-term use of high-dose corticosteroids.

Latest news

More from news
Approximately 4 fully matching, plus 882 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 54 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 45 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics